Brinks Co: Form 10-Q for the period ended Sep 30, 2021
Filed with the SEC on Oct 29, 2021 and accepted by EDGAR at Oct 29, 2021, 13:17 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2021-09-30. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2021-07-01 to 2021-09-30 | $1.08bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Revenue | 9 months2021-01-01 to 2021-09-30 | $3.10bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months2021-07-01 to 2021-09-30 | $837.6m | us-gaap:CostOfRevenue |
| Cost of revenue | 9 months2021-01-01 to 2021-09-30 | $2.42bn | us-gaap:CostOfRevenue |
| Operating income | 3 months2021-07-01 to 2021-09-30 | $74.2m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months2021-01-01 to 2021-09-30 | $209.2m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2021-07-01 to 2021-09-30 | $27.6m | us-gaap:InterestExpense |
| Interest expense | 9 months2021-01-01 to 2021-09-30 | $83.0m | us-gaap:InterestExpense |
| Income tax | 3 months2021-07-01 to 2021-09-30 | $22.9m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months2021-01-01 to 2021-09-30 | $59.2m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2021-07-01 to 2021-09-30 | $19.0m | us-gaap:NetIncomeLoss |
| Net income | 9 months2021-01-01 to 2021-09-30 | $55.6m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2021-07-01 to 2021-09-30 | $0.38 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months2021-01-01 to 2021-09-30 | $1.10 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2021-07-01 to 2021-09-30 | $0.38 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months2021-01-01 to 2021-09-30 | $1.12 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2021-07-01 to 2021-09-30 | 50,300,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months2021-01-01 to 2021-09-30 | 50,400,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months2021-01-01 to 2021-09-30 | $273.6m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 9 months2021-01-01 to 2021-09-30 | $113.7m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 9 months2021-01-01 to 2021-09-30 | $27.3m | us-gaap:PaymentsOfDividendsCommonStock |
| Share repurchases | 9 months2021-01-01 to 2021-09-30 | $50.0m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2021-09-30 | $700.8m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2021-09-30 | $1.96bn | us-gaap:AssetsCurrent |
| Total assets | At period end2021-09-30 | $5.55bn | us-gaap:Assets |
| Current liabilities | At period end2021-09-30 | $1.40bn | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2021-09-30 | $5.30bn | us-gaap:Liabilities |
| Long-term debt | At period end2021-09-30 | $2.70bn | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | At period end2021-09-30 | $136.4m | us-gaap:LongTermDebtCurrent |
| Short-term borrowings | At period end2021-09-30 | $8.1m | us-gaap:ShortTermBorrowings |
| Shareholders' equity | At period end2021-09-30 | $121.4m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0000078890-21-000239. Last ingested by Listed: Nov 4, 2026, 07:32 ET. Listed shows no prices and gives no investment advice.